Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial

Pasireotide G2304 Study Group, for the, Pasireotide G2304 Study Group

Research output: Contribution to journalArticlepeer-review

125 Citations (Scopus)
Original languageEnglish
Pages (from-to)17-26
Number of pages10
JournalThe Lancet Diabetes and Endocrinology
Volume6
Issue number1
DOIs
Publication statusPublished - Jan 2018

ASJC Scopus Subject Areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial'. Together they form a unique fingerprint.

Cite this